Profile photo

GU Oncology With Eleni Efstathiou, MD, PhD

Urology

Dr. Eleni Efstathiou is a Professor of Cancer Medicine and GenitoUrinary Medical Oncology Section Chief at the Houston Methodist Cancer Center. She is known for her breakthrough translational research in prostate cancer. Dr Efstathiou’s main research focus is targeted novel therapeutics as tools to guide marker-driven treatment strategies in prostate cancer, and genomic and non-genomic pathways of resistance.  

STOPCAP Meta-Analysis, TALAPRO-2, and Lu-PSMA-617 Covered at ASCO GU 2025

Dear readers,

In my final post-ASCO GU 2025 newsletter, I wanted to reflect on some research hubs and important studies that I shared over the last month. First, check out the prostate cancer-specific page on GU Oncology Now for all of the essential ASCO GU research in this disease state.

Next, I shared recaps of three important studies: the STOPCAP meta-analysis, TALAPRO-2, and Lu-PSMA-617. Check out all of these studies and more below.

Until next time,
Dr. Eleni Efstathiou

Articles
  • Mashup Score: 2
    Real-World Outcomes of Lu-PSMA-617 in mCRPC | GU Oncology Now - 27 day(s) ago

    Read the full article here

    Tweet Tweets with this article
    • Profile photo of GUOncologyNow
      GUOncologyNow

      📺 Watch Drs. @jordanciuro, @MargoGerke23, and @bilenma of @WinshipAtEmory discuss their research on the real-world outcomes of Lu-PSMA-617 in #mCRPC in a racially diverse patient population: https://t.co/m2trCJ8LXH https://t.co/EpnRGfffEE

  • Mashup Score: 32
    • Profile photo of ASCO
      ASCO

      That’s a wrap on #GU25! Thank you to everyone who made this year’s meeting a success. From groundbreaking science to insightful discussions, your contributions are driving progress in GU oncology. See you next year! https://t.co/K4GtiCrZZQ

      Read the original tweet here

    Tweet Tweets with this article